Free Trial

2 Attractive Large Caps on Sale After Q2 Earnings

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Interpublic Group of Companies Right Now?

Before you consider Interpublic Group of Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Interpublic Group of Companies wasn't on the list.

While Interpublic Group of Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Interpublic Group of Companies (IPG)
4.6635 of 5 stars
$24.200.3%5.45%18.47Hold$32.06
Equifax (EFX)
4.7524 of 5 stars
$263.310.7%0.76%53.85Moderate Buy$295.50
Bristol Myers Squibb (BMY)
4.8945 of 5 stars
$47.40-1.4%5.23%17.75Hold$57.69
Pfizer (PFE)
4.9618 of 5 stars
$24.46-0.5%7.03%17.72Hold$28.55
Berkshire Hathaway (BRK.B)
0.5857 of 5 stars
$473.890.1%N/A12.63Hold$520.00
Acxiom (ACXM)N/A$48.48flatN/AN/AN/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines